Yanina L. Mazzocco Mariotta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yanina L. Mazzocco Mariotta has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Gastón Bergero
Universidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Bioquímica Clínica, Córdoba, Argentina
2 shared publications - Maria Pilar Aoki
Universidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Bioquímica Clínica, Argentina
2 shared publications Martin Rottenberg
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet. Stockholm, Sweden
1 shared publication- Natalia Eberhardt
Department of Medicine, Cardiovascular Research Center, New York University Grossman School of Medicine, New York, New York, USA
1 shared publication - Ruining Liu
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet. Stockholm, Sweden
1 shared publication - Sebastián Del Rosso
Research Center in Clinical Biochemistry and Immunology (CBICI-CONICET), National Scientific and Technical Research Council, National University of Córdoba, Córdoba 5000, Argentina
1 shared publication
Latest Publications
- Open Access
- 13 May 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (13)
Purinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection
Chagas disease, caused by Trypanosoma cruzi , is endemic to Latin America and is characterized by chronic inflammation of cardiac tissues due to parasite persistence. Hypoxia within infected tissues may trigger the stabilization of HIF-1 and be linked to ATP release. Extracellular ATP exhibits microbicidal effects but is scavenged by CD39 and CD73 ectonucleotidases, which ultimately generate adenosine (ADO), a potent immunosuppressor. Here, we comprehensively study the importance of HIF-1 stabilization and the CD39/CD73/ADO axis, on CD4 + T cells with the cytotoxic phenotype, in facilitating the persistence of T. cruzi . Myocardial infection induces prominent areas of hypoxia, which is concomitant with HIF-1α stabilization in T cells and linked to early expansion of CD39 + CD73 + CD4 + T cell infiltrating population. Functional assays further demonstrate that HIF-1 stabilization and CD73 activity are associated with impaired CD4 + T cell cytotoxic potential. RNA-Seq analysis reveals that HIF-1 and purinergic signaling pathways are overrepresented in cardiac tissues of patients with end-stage Chagas disease. The findings highlight a major effect of purinergic signaling on CD4 + T cells with potential cytotoxic capacity in the setting of T. cruzi infection and have translational implications for therapy.
- 13 May 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (13)
Open AccessPurinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection
Chagas disease, caused by Trypanosoma cruzi , is endemic to Latin America and is characterized by chronic inflammation of cardiac tissues due to parasite persistence. Hypoxia within infected tissues may trigger the stabilization of HIF-1 and be linked to ATP release. Extracellular ATP exhibits microbicidal effects but is scavenged by CD39 and CD73 ectonucleotidases, which ultimately generate adenosine (ADO), a potent immunosuppressor. Here, we comprehensively study the importance of HIF-1 stabilization and the CD39/CD73/ADO axis, on CD4 + T cells with the cytotoxic phenotype, in facilitating the persistence of T. cruzi . Myocardial infection induces prominent areas of hypoxia, which is concomitant with HIF-1α stabilization in T cells and linked to early expansion of CD39 + CD73 + CD4 + T cell infiltrating population. Functional assays further demonstrate that HIF-1 stabilization and CD73 activity are associated with impaired CD4 + T cell cytotoxic potential. RNA-Seq analysis reveals that HIF-1 and purinergic signaling pathways are overrepresented in cardiac tissues of patients with end-stage Chagas disease. The findings highlight a major effect of purinergic signaling on CD4 + T cells with potential cytotoxic capacity in the setting of T. cruzi infection and have translational implications for therapy.
- 8 January 2022
- Published by Springer Nature in Purinergic Signalling
- Vol. 18 (1) , 93-113
Purinergic modulation of the immune response to infections
Infectious diseases are caused by the invasion of pathogenic microorganisms such as fungi, bacteria, viruses, and parasites. After infection, disease progression relies on the complex interplay between the host immune response and the microorganism evasion strategies. The host’s survival depends on its ability to mount an efficient protective anti-microbial response to accomplish pathogen clearance while simultaneously preventing tissue injury by keeping under control the excessive inflammatory process. The purinergic system has the dual function of regulating the immune response and triggering effector antimicrobial mechanisms. This review provides an overview of the current knowledge of the modulation of innate and adaptive immunity driven by the purinergic system during parasitic, bacterial and viral infections.
- 8 January 2022
- Published by Springer Nature in Purinergic Signalling
- Vol. 18 (1) , 93-113
Purinergic modulation of the immune response to infections
Infectious diseases are caused by the invasion of pathogenic microorganisms such as fungi, bacteria, viruses, and parasites. After infection, disease progression relies on the complex interplay between the host immune response and the microorganism evasion strategies. The host’s survival depends on its ability to mount an efficient protective anti-microbial response to accomplish pathogen clearance while simultaneously preventing tissue injury by keeping under control the excessive inflammatory process. The purinergic system has the dual function of regulating the immune response and triggering effector antimicrobial mechanisms. This review provides an overview of the current knowledge of the modulation of innate and adaptive immunity driven by the purinergic system during parasitic, bacterial and viral infections.